Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Clinical trial NCT03412383 · UNKNOWN
Trial details
- NCT number
- NCT03412383
- Sponsor
- Peking Union Medical College
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2019-01-25
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.